Skip to main content
8 May 2024
Last updated:
Wednesday 8 May 2024
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
Why AstraZeneca is revisiting olaparib
Read more
The European Lead Factory: A new drug discovery platform for Europe
Read more
How BioCity Nottingham is rebuilding pharma
Read more
Empowering academic drug discovery
Read more
The EU Transparency Directive: Further debate on market access
Read more
What the Myriad case says about gene patenting
Read more
Open innovation at Progenitor Labs
Read more
Investigating the Alzheimer's disease puzzle
Read more
Advanced medical therapies attract investors
Read more
Atlas Venture & Index Ventures focus on startups
Read more
Pagination
First page
« First
Previous page
‹‹
…
Page
53
Page
54
Page
55
Page
56
Current page
57
Page
58
Page
59
Page
60
Page
61
…
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form